NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-214-2016-0-US-01 Human Single Domain Antibodies Targeting CD16A To Mediate ADCC US 62/379,582 Abandoned
NIAID E-147-2015-0-US-06 BROADLY NEUTRALIZING, CROSS REACTIVE ANTIBODIES TO HIV-1 US National Stage 15/121,051 10519222 Issued PDF
NCI E-232-2015-0-PCT-02 T Cells Modified to Overexpress C-MYB PCT PCT PCT/US2016/048435 Expired
NIAID E-293-2011-2-US-07 NUCLEIC ACID MOLECULES ENCODING FERRITIN-HEMAGGLUTININ FUSION PROTEINS US DIV 15/244,321 10137190 Issued PDF
NIAID E-145-2015-4-PCT-01 Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV PCT PCT COMB PCT/US2016/048151 Expired
NCI E-298-2007-0-US-08 IMMUNOSTIMULATORY COMBINATIONS OF TLR LIGANDS AND METHODS OF USE US CON 15/244,882 Abandoned
NIBIB E-006-2016-0-US-01 Systems and Methods for Instant Total Internal Reflection Fluorescence/Structured Illumination Microscopy US 62/378,307 Abandoned
NHLBI E-261-2012-0-US-03 IMAGING METHODS AND COMPUTER-READABLE MEDIA US DIV 15/243,765 11024018 Abandoned PDF
NIBIB E-229-2015-0-PCT-02 Systems And Methods For Multiview Nonlinear Optical Imaging For Improved Signal-to-Noise Ratio And Resolution In Point Scanning Multi-Photon Microscopy PCT PCT PCT/US2016/048058 Expired
NCI E-021-2018-0-US-01 INSTRUMENTED BIOPSY PROBE US 62/378,043 Abandoned
NCI E-090-2000-1-US-14 NOVEL MHC CLASS II RESTRICTED T CELL EPITOPES FROM THE CANCER ANTIGEN NY ESO-1 US CON 15/241,996 10251912 Expired PDF
NCATS E-326-2008-0-AU-12 Activators Of Human Pyruvate Kinase AU DIV 2016216705 Issued
NEI E-134-2016-0-US-01 Selective Estrogen-receptor Modulators (SERMs) Confer Protection Against Photoreceptor Degeneration US 62/377,439 Abandoned
NCATS E-294-2009-0-US-06 Use Of Delta-tocopherol For The Treatment Of Lysosomal Storage Disorders US CON 15/239,753 10039741 Issued PDF
NLM E-124-2017-0-US-01 METHODS FOR IDENTIFYING CLASS 2 CRISPR-CAS SYSTEMS US 62/376,387 Abandoned
NCATS E-262-2016-0-US-01 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS US 62/375,965 Expired
NCI E-254-2005-2-AU-24 Codon Optimized IL-15 and IL-15R Alpha Genes for Expression in Mammalian Cells AU DIV 2016216577 Issued
NIAID E-065-2018-0-PCT-02 COMPOSITIONS COMPRISING PREGNANCY SPECIFIC GLYCOPROTEINS AND METHODS OF USE THEREOF PCT PCT PCT/US2016/052131 Expired
NINDS E-101-2012-1-HK-22 DIHYDROXYPHENYL NEUROTRANSMITTER COMPOUNDS, COMPOSITIONS AND METHODS HK National Stage 16109787.0 Abandoned
NIDDK E-761-2013-0-KR-05 cGAP-PNA Multivalent Peptide Nucleic Acid Ligand Display KR National Stage 10-2016-7022257 Abandoned
NIAID E-051-2002-0-US-18 METHODS FOR USING EXTRACELLULAR ADENOSINE INHIBITORS AND ADENOSINE RECEPTOR INHIBITORS TO ENHANCE IMMUNE RESPONSE AND INFLAMMATION US CON 15/237,316 10314908 Expired PDF
NHGRI E-217-2007-0-JP-13 N-ACETYL MANNOSAMINE AS A THERAPEUTIC AGENT JP DIV 2016-159061 Abandoned
NCI E-132-2012-0-US-05 ALTERING THE IMMUNODOMINANCE HIERARCHY USING A DNA VACCINE EXPRESSING CONSERVED REGIONS US CON 15/235,430 10426830 Issued PDF
NCI E-017-2006-0-US-06 ORGANIC THIOPHOSPHATE ANTIRETROVIRAL AGENTS US CON 15/235,847 Abandoned
NCATS E-202-2016-2-US-01 Repurposing CDK Inhibitors For Treatment Of Zika Virus Infection US 62/374,467 Abandoned
NCI E-204-2015-0-PCT-02 Near-IR Light-Cleavable Conjugates and Conjugate Precursors PCT PCT PCT/US2016/046582 Abandoned
NINDS E-143-2002-1-US-48 Method For The Treatment Of Multiple Sclerosis US CON 15/234,575 Abandoned
NCATS E-240-2011-0-US-03 GALACTOKINASE INHIBITORS FOR THE TREATMENT AND PREVENTION OF ASSOCIATED DISEASES AND DISORDERS US CON 15/234,934 Abandoned
NCATS E-229-2016-0-US-01 PEPTIDE INHIBITORS OF PHOSPHOGLYCERATE MUTASE AND METHODS OF USE US 62/373,835 Abandoned
NCI E-245-2016-0-US-01 NEAR-IR LIGHT-CLEAVABLE CONJUGATES AND CONJUGATE PRECURSORSNguy US 62/373,666 Abandoned
NICHD E-173-2016-0-US-01 Multi-Dimensional Spectroscopic NMR And MRI Using Marginal Distributions US 62/373,497 Abandoned
CC E-026-2015-0-PCT-02 Repeat Biopsy System And Method PCT PCT PCT/IB2016/054805 Expired
NIAID E-255-2016-0-US-03 CD-4 Mimetic Small Molecules Sensitize Human Immunogenicity Virus To Vaccine-elicited Antibody US National Stage 15/117,866 Abandoned
NIDCR E-190-2015-0-PCT-02 Methods Of Using Neodymium Magnet For Rapid Diagnosis Of Infectious And Autoimmune Diseases PCT PCT PCT/US2016/046037 Expired
NICHD E-206-2007-0-US-10 SUBSTRATE REDUCTION THERAPY US DIV 15/231,279 Abandoned
NCATS E-281-2015-0-US-12 PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER US National Stage 15/750,805 10899710 Issued PDF
NCATS E-281-2015-0-IN-07 PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER IN National Stage 201837005050 Abandoned
NCATS E-281-2015-0-KR-09 PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER KR National Stage 10-2018-7006536 Abandoned
NCATS E-281-2015-0-AU-03 NOVEL PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER AU National Stage 2016306276 Abandoned
NCATS E-281-2015-0-PCT-02 NOVEL PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER PCT PCT PCT/US2016/045731 Expired
NCI E-079-2016-0-US-03 Biomarkers for Assessing Cancer Patients for Treatment US National Stage 15/116,925 Abandoned
NCATS E-281-2015-0-CN-14 NOVEL PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER CN National Stage 201680046606.6 Abandoned
NCATS E-281-2015-0-EP-06 NOVEL PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER EP National Stage 16759907.5 Abandoned
NCATS E-281-2015-0-CA-05 NOVEL PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER CA National Stage 2995077 Pending
NCATS E-281-2015-0-BR-04 NOVEL PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER BR National Stage BR1120180025992 Pending
NCATS E-281-2015-0-ZA-13 NOVEL PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER ZA National Stage 2018/01476 Pending
NCATS E-281-2015-0-MX-10 NOVEL PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER MX National Stage MX/a/2018/001576 Pending
NCATS E-281-2015-0-RU-11 NOVEL PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER RU National Stage 2018107879 Pending
NCI E-234-2014-1-IL-07 METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF IL National Stage 247095 Issued
NIAID E-055-2007-3-US-05 USE OF ANTAGONISTS OF THE INTERACTION BETWEEN HIV GP120 AND A4B7 INTEGRIN US CON 15/227,879 9896509 Issued PDF